159 related articles for article (PubMed ID: 37988371)
21. miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.
Wang G; Zhou Y; Chen W; Yang Y; Ye J; Ou H; Wu H
Cancer Biomark; 2020; 28(4):549-559. PubMed ID: 32623387
[TBL] [Abstract][Full Text] [Related]
22. Hypoxic tumor-derived exosomal miR-31-5p promotes lung adenocarcinoma metastasis by negatively regulating SATB2-reversed EMT and activating MEK/ERK signaling.
Yu F; Liang M; Huang Y; Wu W; Zheng B; Chen C
J Exp Clin Cancer Res; 2021 Jun; 40(1):179. PubMed ID: 34074322
[TBL] [Abstract][Full Text] [Related]
23. Circ-HMGA2 (hsa_circ_0027446) promotes the metastasis and epithelial-mesenchymal transition of lung adenocarcinoma cells through the miR-1236-3p/ZEB1 axis.
Yu Z; Zhu X; Li Y; Liang M; Liu M; Liu Z; Qin L; Wu X; Du K; Liu L; Wang Y; Zheng Y
Cell Death Dis; 2021 Mar; 12(4):313. PubMed ID: 33762580
[TBL] [Abstract][Full Text] [Related]
24. MELK is an oncogenic kinase essential for metastasis, mitotic progression, and programmed death in lung carcinoma.
Tang Q; Li W; Zheng X; Ren L; Liu J; Li S; Wang J; Du G
Signal Transduct Target Ther; 2020 Dec; 5(1):279. PubMed ID: 33262323
[TBL] [Abstract][Full Text] [Related]
25. Single-Cell Transcriptome Profiling of Thyroid Hormone Effectors in the Human Fetal Neocortex: Expression of
Diez D; Morte B; Bernal J
Thyroid; 2021 Oct; 31(10):1577-1588. PubMed ID: 34114484
[No Abstract] [Full Text] [Related]
26. Methyltransferase SETD2 inhibits tumor growth and metastasis via STAT1-IL-8 signaling-mediated epithelial-mesenchymal transition in lung adenocarcinoma.
Yang X; Chen R; Chen Y; Zhou Y; Wu C; Li Q; Wu J; Hu WW; Zhao WQ; Wei W; Shi JT; Ji M
Cancer Sci; 2022 Apr; 113(4):1195-1207. PubMed ID: 35152527
[TBL] [Abstract][Full Text] [Related]
27. Invasive FoxM1 phosphorylated by PLK1 induces the polarization of tumor-associated macrophages to promote immune escape and metastasis, amplified by IFITM1.
Xu R; Lee YJ; Kim CH; Min GH; Kim YB; Park JW; Kim DH; Kim JH; Yim H
J Exp Clin Cancer Res; 2023 Nov; 42(1):302. PubMed ID: 37968723
[TBL] [Abstract][Full Text] [Related]
28. Identification of a novel therapeutic candidate, NRK, in primary cancer-associated fibroblasts of lung adenocarcinoma microenvironment.
Wei T; Song J; Liang K; Li L; Mo X; Huang Z; Chen G; Mao N; Yang J
J Cancer Res Clin Oncol; 2021 Apr; 147(4):1049-1064. PubMed ID: 33387038
[TBL] [Abstract][Full Text] [Related]
29. Cancer/testis antigen LDHC promotes proliferation and metastasis by activating the PI3K/Akt/GSK-3β-signaling pathway and the in lung adenocarcinoma.
Chen L; Wu Q; Xu X; Yang C; You J; Chen F; Zeng Y
Exp Cell Res; 2021 Jan; 398(2):112414. PubMed ID: 33301764
[TBL] [Abstract][Full Text] [Related]
30. SERPINB5 is a prognostic biomarker and promotes proliferation, metastasis and epithelial-mesenchymal transition (EMT) in lung adenocarcinoma.
He X; Ma Y; Huang Z; Wang G; Wang W; Zhang R; Guo G; Zhang X; Wen Y; Zhang L
Thorac Cancer; 2023 Aug; 14(23):2275-2287. PubMed ID: 37424293
[TBL] [Abstract][Full Text] [Related]
31. TFAP2A Induced ITPKA Serves as an Oncogene and Interacts with DBN1 in Lung Adenocarcinoma.
Guoren Z; Zhaohui F; Wei Z; Mei W; Yuan W; Lin S; Xiaoyue X; Xiaomei Z; Bo S
Int J Biol Sci; 2020; 16(3):504-514. PubMed ID: 32015686
[TBL] [Abstract][Full Text] [Related]
32. High expression of keratin 6C is associated with poor prognosis and accelerates cancer proliferation and migration by modulating epithelial-mesenchymal transition in lung adenocarcinoma.
Hu HB; Yang XP; Zhou PX; Yang XA; Yin B
Genes Genomics; 2020 Feb; 42(2):179-188. PubMed ID: 31768767
[TBL] [Abstract][Full Text] [Related]
33. Phosphorylation of human enhancer filamentation 1 (HEF1) stimulates interaction with Polo-like kinase 1 leading to HEF1 localization to focal adhesions.
Lee KH; Hwang JA; Kim SO; Kim JH; Shin SC; Kim EE; Lee KS; Rhee K; Jeon BH; Bang JK; Cha-Molstad H; Soung NK; Jang JH; Ko SK; Lee HG; Ahn JS; Kwon YT; Kim BY
J Biol Chem; 2018 Jan; 293(3):847-862. PubMed ID: 29191835
[TBL] [Abstract][Full Text] [Related]
34. Synaptotagmin 12 (SYT12) Gene Expression Promotes Cell Proliferation and Progression of Lung Adenocarcinoma and Involves the Phosphoinositide 3-Kinase (PI3K)/AKT/Mammalian Target of Rapamycin (mTOR) Pathway.
Liu K; Luo J; Shao C; Ren Z; Sun S; Zhu Y; Zhou H; Jiang Z; Li X; Gu W; Xu Y; Qiang Y; Ren B; Xu L; Wu H; Shen Y
Med Sci Monit; 2020 Feb; 26():e920351. PubMed ID: 32108133
[TBL] [Abstract][Full Text] [Related]
35. Localized T3 production modifies the transcriptome and promotes the hepatocyte-like lineage in iPSC-derived hepatic organoids.
Hidalgo-Álvarez J; Salas-Lucia F; Vera Cruz D; Fonseca TL; Bianco AC
JCI Insight; 2023 Dec; 8(23):. PubMed ID: 37856222
[TBL] [Abstract][Full Text] [Related]
36. The hepatic microenvironment promotes lung adenocarcinoma cell proliferation, metastasis, and epithelial-mesenchymal transition via METTL3-mediated N6-methyladenosine modification of
Ni XF; Xie QQ; Zhao JM; Xu YJ; Ji M; Hu WW; Wu J; Wu CP
Aging (Albany NY); 2021 Jan; 13(3):4357-4369. PubMed ID: 33495421
[TBL] [Abstract][Full Text] [Related]
37. Tanshinone IIA suppresses the progression of lung adenocarcinoma through regulating CCNA2-CDK2 complex and AURKA/PLK1 pathway.
Li Z; Zhang Y; Zhou Y; Wang F; Yin C; Ding L; Zhang S
Sci Rep; 2021 Dec; 11(1):23681. PubMed ID: 34880385
[TBL] [Abstract][Full Text] [Related]
38. CLDN18.1 attenuates malignancy and related signaling pathways of lung adenocarcinoma in vivo and in vitro.
Luo J; Chimge NO; Zhou B; Flodby P; Castaldi A; Firth AL; Liu Y; Wang H; Yang C; Marconett CN; Crandall ED; Offringa IA; Frenkel B; Borok Z
Int J Cancer; 2018 Dec; 143(12):3169-3180. PubMed ID: 30325015
[TBL] [Abstract][Full Text] [Related]
39. LPCAT1 promotes brain metastasis of lung adenocarcinoma by up-regulating PI3K/AKT/MYC pathway.
Wei C; Dong X; Lu H; Tong F; Chen L; Zhang R; Dong J; Hu Y; Wu G; Dong X
J Exp Clin Cancer Res; 2019 Feb; 38(1):95. PubMed ID: 30791942
[TBL] [Abstract][Full Text] [Related]
40. Integrated thyroid endocrine disrupting effect on zebrafish (Danio rario) larvae via simultaneously repressing type II iodothyronine deiodinase and activating thyroid receptor-mediated signaling following waterborne exposure to trace azocyclotin.
Jiao F; Qiao K; Jiang Y; Li S; Zhao J; Gui W
Environ Pollut; 2019 Dec; 255(Pt 2):113328. PubMed ID: 31671316
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
